Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Arcadia Biosciences (RKDA) Shares Outstanding (2016 - 2025)

Arcadia Biosciences (RKDA) has disclosed Shares Outstanding for 12 consecutive years, with $1.4 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Shares Outstanding changed 0.18% year-over-year to $1.4 million, compared with a TTM value of $1.4 million through Sep 2025, changed 0.18%, and an annual FY2024 reading of $1.4 million, up 6.19% over the prior year.
  • Shares Outstanding was $1.4 million for Q3 2025 at Arcadia Biosciences, roughly flat from $1.4 million in the prior quarter.
  • Across five years, Shares Outstanding topped out at $22.2 million in Q3 2021 and bottomed at $554609.0 in Q4 2021.
  • Average Shares Outstanding over 5 years is $4.3 million, with a median of $1.4 million recorded in 2024.
  • The sharpest move saw Shares Outstanding skyrocketed 146.55% in 2021, then tumbled 97.4% in 2022.
  • Year by year, Shares Outstanding stood at $554609.0 in 2021, then grew by 11.08% to $616079.0 in 2022, then soared by 108.63% to $1.3 million in 2023, then increased by 6.19% to $1.4 million in 2024, then grew by 0.18% to $1.4 million in 2025.
  • Business Quant data shows Shares Outstanding for RKDA at $1.4 million in Q3 2025, $1.4 million in Q2 2025, and $1.4 million in Q1 2025.